Atara Biotherapeutics, Inc. (ATRA)
9.48
+1.02
(+12.06%)
USD |
NASDAQ |
Oct 02, 16:00
9.60
+0.12
(+1.27%)
After-Hours: 20:00
Atara Biotherapeutics Price : 9.48 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 8.46 | 9.675 | 8.25 | 9.48 | 85752.00 |
| Oct 01, 2026 | 8.73 | 9.20 | 8.23 | 8.46 | 90929.00 |
| Sep 30, 2026 | 8.08 | 8.710 | 7.83 | 8.50 | 29302.00 |
| Sep 29, 2026 | 8.33 | 8.821 | 7.89 | 8.05 | 56451.00 |
| Sep 28, 2026 | 8.69 | 8.705 | 8.336 | 8.37 | 23529.00 |
| Sep 25, 2026 | 8.60 | 8.99 | 8.535 | 8.81 | 31197.00 |
| Sep 24, 2026 | 8.60 | 8.86 | 8.33 | 8.54 | 20777.00 |
| Sep 23, 2026 | 8.92 | 8.95 | 8.40 | 8.56 | 40473.00 |
| Sep 22, 2026 | 9.30 | 9.60 | 8.93 | 8.93 | 27265.00 |
| Sep 21, 2026 | 9.69 | 9.92 | 9.30 | 9.38 | 29670.00 |
| Sep 18, 2026 | 9.73 | 10.19 | 9.60 | 9.69 | 37766.00 |
| Sep 17, 2026 | 10.28 | 10.28 | 9.41 | 9.71 | 26421.00 |
| Sep 16, 2026 | 9.50 | 10.37 | 9.07 | 10.11 | 116745.0 |
| Sep 15, 2026 | 9.21 | 9.88 | 8.92 | 9.44 | 56062.00 |
| Sep 14, 2026 | 9.09 | 9.71 | 9.07 | 9.25 | 50848.00 |
| Sep 11, 2026 | 10.00 | 10.00 | 9.38 | 9.38 | 16034.00 |
| Sep 10, 2026 | 9.94 | 9.94 | 9.52 | 9.89 | 23205.00 |
| Sep 09, 2026 | 10.27 | 10.43 | 9.76 | 9.91 | 68510.00 |
| Sep 08, 2026 | 10.60 | 11.33 | 10.23 | 10.23 | 106940.0 |
| Sep 04, 2026 | 9.45 | 9.95 | 9.25 | 9.76 | 135656.0 |
| Sep 03, 2026 | 9.49 | 9.53 | 9.00 | 9.53 | 25276.00 |
| Sep 02, 2026 | 9.08 | 9.48 | 9.08 | 9.44 | 20899.00 |
| Sep 01, 2026 | 8.96 | 9.18 | 8.80 | 9.02 | 51945.00 |
| Aug 31, 2026 | 9.09 | 9.29 | 8.83 | 8.90 | 30242.00 |
| Aug 28, 2026 | 9.18 | 9.21 | 8.90 | 9.20 | 15346.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 19.95 |
| Alnylam Pharmaceuticals, Inc. | 219.72 |
| Savara, Inc. | 4.81 |
| Vericel Corp. | 40.15 |
| Biogen, Inc. | 219.88 |
Price Related Metrics
| PS Ratio | 19.13 |
| PEG Ratio | -0.0296 |
| Earnings Yield | -14.75% |
| Market Cap | 89.52M |
| PEGY Ratio | -0.0296 |